DAIICHI SANKYO, INC.
- Country
- ๐ฏ๐ตJapan
- Ownership
- Subsidiary
- Established
- 2010-01-01
- Employees
- 10K
- Market Cap
- $79B
- Website
- http://daiichisankyo.us
Exatecan Mesylate in Treating Patients With Ewing's Sarcoma, Primitive Neuroectodermal Tumor, or Desmoplastic Small Round Cell Tumor
- Conditions
- Sarcoma
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00055952
- Locations
- ๐บ๐ธ
University of Colorado Cancer Center at University of Colorado Health Sciences Center, Denver, Colorado, United States
๐บ๐ธNemours Children's Clinic, Jacksonville, Florida, United States
๐บ๐ธCancer Institute of New Jersey, New Brunswick, New Jersey, United States
DX-8951f in Treating Patients With Metastatic Stomach Cancer
- Conditions
- Gastric CancerEsophageal Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00017212
- Locations
- ๐บ๐ธ
Pacific Shores Medical Group, Long Beach, California, United States
๐บ๐ธRocky Mountain Cancer Centers, Denver, Colorado, United States
๐บ๐ธSimmons Cancer Center - Dallas, Dallas, Texas, United States
DX-8951f in Treating Women Who Have Advanced or Recurrent Cancer of the Cervix
- Conditions
- Cervical Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00004866
- Locations
- ๐บ๐ธ
Albert Einstein Clinical Cancer Center, Bronx, New York, United States
๐บ๐ธSt. Luke's-Roosevelt Hospital, New York, New York, United States
๐บ๐ธRuppert Health Center, Toledo, Ohio, United States
DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas
- Conditions
- Brain and Central Nervous System TumorsLymphomaUnspecified Childhood Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00004212
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
๐บ๐ธSt. Jude Children's Research Hospital, Memphis, Tennessee, United States
๐บ๐ธChildren's Medical Center of Dallas, Dallas, Texas, United States
Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00023972
- Locations
- ๐บ๐ธ
Intouch Research, Huntsville, Alabama, United States
๐บ๐ธProvidence Cancer Center, Mobile, Alabama, United States
๐บ๐ธArizona Clinical Research Center, Tucson, Arizona, United States
Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer
- Conditions
- Head and Neck CancerOral ComplicationsRadiation Toxicity
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-05-16
- Lead Sponsor
- Daiichi Sankyo
- Registration Number
- NCT00017511
- Locations
- ๐บ๐ธ
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
๐บ๐ธMobile Infirmary Medical Center, Mobile, Alabama, United States
๐บ๐ธCranial Pain Research, Tucson, Arizona, United States